| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $692.2M | -20.8% |
| Cost of Revenue | $322.6M | -1.8% |
| Gross Profit | $369.6M | -32.2% |
| R&D Expense | $4.4M | -4.3% |
| SG&A Expense | $78.4M | -1.6% |
| Operating Income | -$203.2M | +31.7% |
| Interest Expense | $3.4M | +528.4% |
| Pre-tax Income | -$197.2M | +19.1% |
| Income Tax | -$3.1M |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $80.1M | -23.0% |
| Accounts Receivable | $866K | -29.3% |
| Inventory | $54.1M | -59.3% |
| Current Assets | $186.5M | -37.7% |
| Total Assets | $443.4M | -30.5% |
| Current Liabilities | $184.6M | -21.8% |
| Long-term Debt | $49.4M | — |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$47.2M | +78.1% |
| Capital Expenditures | $26.5M | -66.0% |
| Investing Cash Flow | -$26.5M | +78.8% |
| Financing Cash Flow | $47.6M | -87.8% |
| Free Cash Flow | -$73.7M | +74.9% |
| +80.4% |
| Net Income | -$194.2M | +15.0% |
| EPS (Basic) | -$0.63 | +24.1% |
| EPS (Diluted) | -$0.63 | +24.1% |
| Total Liabilities |
| $231.9M |
| -8.1% |
| Stockholders' Equity | $211.5M | -45.1% |